Clinical Trials · NCT01886287
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Enrollment
- 2
- Start date
- Dec 2013
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants With Improved Frequency of Diarrhea